Evaluation of the factor Xa inhibitor, PRT054021, against enoxaparin in a randomized trial for the prevention of venous thromboembolic events after unilateral total knee replacement (EXPERT),
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Betrixaban; Enoxaparin sodium
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Therapeutic Use
- Acronyms EXPERT
- 10 Sep 2007 Status changed from recruiting to completed.
- 06 Jul 2007 Results have been presented.